tradingkey.logo
tradingkey.logo
검색

Twist Bioscience Corp

TWST
관심 목록에 추가
49.170USD
-3.780-7.14%
종가 05/15, 16:00ET시세는 15분 지연됩니다
3.06B시가총액
손실P/E TTM

Twist Bioscience Corp

49.170
-3.780-7.14%

자세한 내용은 Twist Bioscience Corp 회사

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.

Twist Bioscience Corp 정보

종목 코드 TWST
회사 이름Twist Bioscience Corp
상장일Oct 31, 2018
CEOLeproust (Emily M)
직원 수979
유형Ordinary Share
회계 연도 종료Oct 31
주소681 Gateway Blvd.
도시SOUTH SAN FRANCISCO
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94080
전화18007190671
웹사이트https://www.twistbioscience.com/
종목 코드 TWST
상장일Oct 31, 2018
CEOLeproust (Emily M)

Twist Bioscience Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
398.19K
-1.29%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
69.20K
-4.11%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
52.14K
-3.76%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
26.07K
-4.28%
Dr. Melissa A. Starovasnik, Ph.D.
Dr. Melissa A. Starovasnik, Ph.D.
Independent Director
Independent Director
20.75K
-7.23%
Mr. Jan Johannessen
Mr. Jan Johannessen
Independent Director
Independent Director
13.28K
--
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
13.14K
-73.06%
Mr. Robert B. (Rob) Chess
Mr. Robert B. (Rob) Chess
Lead Independent Director
Lead Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
398.19K
-1.29%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
69.20K
-4.11%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
52.14K
-3.76%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
26.07K
-4.28%

수익 분석

통화: USD마지막 업데이트: Mon, Apr 6
통화: USD마지막 업데이트: Mon, Apr 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
NGS applications
52.64M
50.76%
DNA synthesis and protein solutions
51.06M
49.24%
지역별USD
이름
수익
비율
Americas
58.38M
56.30%
EMEA
38.37M
37.00%
APAC
6.95M
6.70%
사업별
지역별
사업별USD
이름
수익
비율
NGS applications
52.64M
50.76%
DNA synthesis and protein solutions
51.06M
49.24%

주식 보유 통계

마지막 업데이트: Sun, May 10
마지막 업데이트: Sun, May 10
주주
주주 유형
주주
주주
비율
Artisan Partners Limited Partnership
10.23%
ARK Investment Management LLC
10.19%
EdgePoint Investment Group Inc.
8.64%
William Blair Investment Management, LLC
8.46%
BlackRock Institutional Trust Company, N.A.
7.71%
기타
54.78%
주주
주주
비율
Artisan Partners Limited Partnership
10.23%
ARK Investment Management LLC
10.19%
EdgePoint Investment Group Inc.
8.64%
William Blair Investment Management, LLC
8.46%
BlackRock Institutional Trust Company, N.A.
7.71%
기타
54.78%
주주 유형
주주
비율
Investment Advisor
64.84%
Investment Advisor/Hedge Fund
35.76%
Hedge Fund
8.42%
Research Firm
5.50%
Pension Fund
1.72%
Individual Investor
1.41%
Bank and Trust
0.59%
Family Office
0.16%
Insurance Company
0.03%

기관 주식 보유

마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
592
78.48M
126.03%
-339.29K
2025Q4
585
73.72M
120.24%
-3.30M
2025Q3
566
71.88M
119.09%
+752.75K
2025Q2
575
70.44M
116.72%
-302.44K
2025Q1
585
70.23M
117.22%
-1.63M
2024Q4
578
67.47M
113.11%
-8.03M
2024Q3
588
67.80M
115.74%
-8.48M
2024Q2
579
66.59M
114.39%
-10.53M
2024Q1
565
68.18M
117.94%
-8.61M
2023Q4
559
67.81M
117.39%
-11.70M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Artisan Partners Limited Partnership
6.22M
10.14%
+387.01K
+6.64%
Feb 27, 2026
ARK Investment Management LLC
7.56M
12.33%
+832.69K
+12.38%
Dec 31, 2025
EdgePoint Investment Group Inc.
5.38M
8.77%
+1.30M
+31.74%
Dec 31, 2025
William Blair Investment Management, LLC
5.95M
9.71%
+1.81M
+43.75%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
4.80M
7.83%
-12.17K
-0.25%
Dec 31, 2025
State Street Investment Management (US)
3.63M
5.92%
+538.75K
+17.44%
Dec 31, 2025
Soleus Capital Management, L.P.
1.86M
3.04%
-4.43K
-0.24%
Dec 31, 2025
Goldman Sachs & Company, Inc.
1.50M
2.45%
+189.78K
+14.49%
Dec 31, 2025
더 보기

관련 ETF

마지막 업데이트: Tue, Dec 2
마지막 업데이트: Tue, Dec 2
이름
비율
ARK Genomic Revolution ETF
6.24%
iShares Genomics Immunology and Healthcare ETF
3.92%
Global X Genomics & Biotechnology ETF
2.09%
ROBO Global Healthcare Technology & Innovation ETF
2%
WisdomTree BioRevolution Fund
1.79%
ARK Innovation ETF
1.47%
Franklin Genomic Advancements ETF
1.17%
State Street SPDR S&P Biotech ETF
0.92%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.66%
Direxion Daily S&P Biotech Bull 3X Shares
0.56%
더 보기
ARK Genomic Revolution ETF
비율6.24%
iShares Genomics Immunology and Healthcare ETF
비율3.92%
Global X Genomics & Biotechnology ETF
비율2.09%
ROBO Global Healthcare Technology & Innovation ETF
비율2%
WisdomTree BioRevolution Fund
비율1.79%
ARK Innovation ETF
비율1.47%
Franklin Genomic Advancements ETF
비율1.17%
State Street SPDR S&P Biotech ETF
비율0.92%
First Trust Nasdaq Lux Digi Health Solutions ETF
비율0.66%
Direxion Daily S&P Biotech Bull 3X Shares
비율0.56%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI